ENDRA LIFE SCIENCES INC. Derivative Liability, Noncurrent
ENDRA LIFE SCIENCES INC. (NDRA) had Derivative Liability, Noncurrent of $555.31 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DerivativeLiabilitiesNoncurrent · last filed 2026-08-14
- 2026-06-30: Derivative Liability, Noncurrent $555.31K.
- 2026-03-31: Derivative Liability, Noncurrent $488.60K.
- 2025-12-31: Derivative Liability, Noncurrent $479.75K.
- 2025-09-30: Derivative Liability, Noncurrent $595.88K.
| Period end | Derivative Liability, Noncurrent |
|---|---|
| 2026-06-30 | $555.31K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $488.60K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $479.75K 10-Q · filed 2026-08-14 |
| 2025-09-30 | $595.88K 10-Q · filed 2025-11-14 |
| 2024-12-31 | $799.28K 10-K · filed 2026-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |